全球定序儀市場：2023-2028

本報告調查了全球定序儀市場，並提供了市場趨勢以及截至2023年的歷史資料和截至2028年的預測資料。還全面介紹了進入市場的公司的概況。

目錄

第1章 執行摘要

第2章 市場發展及趨勢

• 定序儀市場穩定，但也有變化的跡象
• 主要供應商的定序器系統和效能
• 特價訊息
• 趨勢
• 臨床應用
• 液體切片、循環核酸
• 監管和標準化工作
• 透過去中心化改善存取
• 競爭加劇的可能性
• NGS 技術的進步
• 長讀取序列
• 單細胞定序
• 表觀遺傳定序
• 高通量定序
• 即時序列
• 攜帶式定序設備
• 直接RNA定序
• 空間轉錄組學
• 宏基因體學、微生物組
• 多組學整合

第3章 市場分析

• 摘要
• 依產品類型劃分的定序儀市場
• 定序儀市場，依國家劃分
• 市佔率

第4章 公司簡介

• 10X Genomics
• Agilent Technologies
• BGI (Beijing Genomics Inst.)
• 產前檢測
• 測試服務
• 全基因組定序（WGS）
• NGS 定序
• 合作
• Berry Genomics
• CareDx
• CareDx 提供的檢查服務
• CareDx 提供的產品
• 元素生物科學
• 精確的科學
• 近期營收和趨勢
• Illumina
• 診斷
• 其他合作和公告
• 中國
• New England Biolabs
• Oxford Nanopore Technologies
• Pacific Biosciences (PacBio)
• 背景和其他訊息
• Qiagen
• 液態生檢
• Revvity
• 定序/基因組學
• 液體活檢
• 產前業務
• 實驗室服務
• Singular Genomic
• Takara Bio
• Tecan
• Thermo Fisher Scientific
• 次世代定序
• 移植醫學
• 微生物組
• 其他合作和收購
• 基因編輯與細胞治療
• Ultima Genomics

Kalorama Information's new comprehensive report, "Worldwide Sequencer Market, 2023-2028", provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.

The report offers historical data for 2023 and forecast data through 2028, focusing on the market for sequencing systems and products. This encompasses systems, consumables, software, and system servicing, related to the DNA and RNA sequencing process.

Kalorama Information has been closely monitoring the market for next-generation sequencing (NGS) systems since their inception. The report discusses the rapid growth and transformation of the sequencing market over the past decade, driven by technological advancements, expanding applications, and decreasing costs. It provides comprehensive insights into market share, revenue growth, competitive dynamics, and company profiles.

NGS technology has become a staple in the life sciences, offering significant improvements in performance and output while reducing costs in line with Moore's Law. Some systems now enable genome sequencing at costs as low as $100-$200. The technology is widely used for applications including:

• Whole genome sequencing
• Targeted/amplicon resequencing
• Exome sequencing
• SNP analysis
• RNA sequencing
• Gene expression profiling
• Transcriptomics
• Small RNA/miRNA analysis
• ChIP-seq
• Methylation analysis
• Metagenomics

"Worldwide Sequencer Market, 2023-2028" provides a comprehensive overview of these applications and examines the trends and challenges shaping the future of the sequencing market.

Kalorama Information's new comprehensive report, Worldwide Sequencer Market, 2023-2028 , provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.

The report offers historical data for 2023 and forecast data through 2028, focusing on the market for sequencing systems and products. This encompasses systems, consumables, software, and system servicing, related to the DNA and RNA sequencing process."

Kalorama Information has been closely monitoring the market for next-generation sequencing (NGS) systems since their inception. The report discusses the rapid growth and transformation of the sequencing market over the past decade, driven by technological advancements, expanding applications, and decreasing costs. It provides comprehensive insights into market share, revenue growth, competitive dynamics, and company profiles.

NGS technology has become a staple in the life sciences, offering significant improvements in performance and output while reducing costs in line with Moore's Law. Some systems now enable genome sequencing at costs as low as $100-$200. The technology is widely used for applications including:

• Whole genome sequencing
• Targeted/amplicon resequencing
• Exome sequencing
• SNP analysis
• RNA sequencing
• Gene expression profiling
• Transcriptomics
• Small RNA/miRNA analysis
• ChIP-seq
• Methylation analysis
• Metagenomics

Worldwide Sequencer Market, 2023-2028 provides a comprehensive overview of these applications and examines the trends and challenges shaping the future of the sequencing market.

Table of Contents

Chapter 1: Executive Summary

• Table 1-1: World Sequencer Market, 2023-2028 (in $ millions)
• Figure 1-1: World Sequencer Market, 2023-2028 (in $ millions)
• Figure 1-2: Annual Growth in World Sequencer Market, 2023-2028 (%)
• Table 1-2: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
• Figure 1-3: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
• Figure 1-4: World Sequencer Market Compound Annual Growth Rate (CAGR), by Product Segment, 2023-2028 (%)
• Table 1-3: World Sequencer Market, Shares by Product Segment, 2023-2028 (%)
• Figure 1-5: World Sequencer Market, Shares by Product Segment, 2023 (%)
• Figure 1-6: Cost of Sequencing a Human Genome, 2001-2023 (in $ millions)
• Current Trends
• Scope and Methodology
• Report Structure

Chapter 2: Market Development and Trends

• Sequencer Market Stable But Poised for Changes
• Major Vendors' Sequencer Systems and Performance
  • Table 2-1: Selected Short-Read Sequencer Systems' Performance, 2024
  • Table 2-2: Selected Long-Read Sequencer Systems' Performance, 2024
• Deals
  • Table 2-3: Deals in Sequencer Market, January 2020-July 2024
• Trends
• Clinical Applications
• Liquid Biopsy, Circulating Nucleic Acids
• Regulatory and Standardization Efforts
• Increased Access Through Decentralization
• Potential for Increasing Competition
• Advancements in NGS Technology
• Long-Read Sequencing
• Single Cell Sequencing
• Epigenetic Sequencing
• High-Throughput Sequencing
• Real-time Sequencing
• Portable Sequencing Devices
• Direct RNA Sequencing
• Spatial Transcriptomics
• Metagenomics, Microbiome
• Multi-Omics Integration

Chapter 3: Market Analysis

• Overview
  • Table 3-1: World Sequencer Market, 2023-2028 (in $ millions)
  • Figure 3-1: World Sequencer Market, 2023-2028 (in $ millions)
  • Figure 3-2: Illumina Revenue Annual Growth Rate, 2010-2023 (%)
  • Figure 3-3: Illumina Revenue Growth Rate 4-Year Moving Average, 2014-2023 (in $ millions)
• Sequencer Market by Product Types
  • Table 3-2: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
  • Table 3-3: World Sequencer Market, Shares by Product Segment, 2023-2028 (%)
  • Figure 3-4: World Sequencer Market, Share by Product Segment, 2023 (%)
  • Figure 3-5: World Sequencer Market, Share by Product Segment, 2028 (%)
• Sequencer Market by Country and Region
  • Table 3-4: Geographic Breakout of the World Sequencer Market, by Country/Region (APAC, Europe, North America, Rest of World), 2023 (in $ millions)
  • Figure 3-6: Geographic Breakout of the World Sequencer Market, by Country/Region (APAC, Europe, North America, Rest of World), 2023 (in $ millions)
  • Figure 3-7: Geographic Breakout of the World Sequencer Market, Share by Country/Region (APAC, Europe, North America, Rest of World), 2023 (%)
• Market Shares
  • Figure 3-8: World Sequencer Market, by Estimated Market Shares, by Company (Agilent, Illumina, MGI Tech, MilliporeSigma, Oxford Nanopore, Pacific Biosciences, Qiagen, Roche, Thermo Fisher, Other), 2023 (%)

Chapter 4: Company Profiles

• 10X Genomics
• Agilent Technologies
• BGI (Beijing Genomics Inst.)
• Prenatal Testing
• Test Services
• Whole Genome Sequencing (WGS)
• NGS Sequencing
• Collaborations
• Berry Genomics
• CareDx
  • Figure 4-1: CareDx Revenue, 2017-Q1 2024 (in $ millions)
• Testing Services Offered by CareDx
  • AlloMap Tests
  • AlloSure Tests
• Products Offered by CareDx
• Element Biosciences
• Exact Sciences
• Recent Revenues and Developments
• Illumina
  • Table 4-1: Illumina's Revenue History, 2015-2023 (in $ millions)
  • Figure 4-2: Illumina's Revenue History, 2017-Q1 2024 (in $ millions)
• Diagnostics
• Other Collaborations and Announcements
• China
• New England Biolabs
• Oxford Nanopore Technologies
• Pacific Biosciences (PacBio)
• Background and Other Announcements
• Qiagen
• Liquid Biopsy
• Revvity
• Sequencing/Genomics
• Liquid Biopsy
• Prenatal Business
• Lab Services
• Singular Genomic
• Takara Bio
• Tecan
• Thermo Fisher Scientific
• Next-Generation Sequencing
• Transplant Medicine
• Microbiome
• Other Collaborations and Acquisitions
• Gene Editing and Cell Therapy
• Ultima Genomics